Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on September 20, 2007

Stroke. 2007
Published online before print September 20, 2007, doi: 10.1161/STROKEAHA.107.486068
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/11/2912    most recent
STROKEAHA.107.486068v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weikert, C.
Right arrow Articles by Boeing, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weikert, C.
Right arrow Articles by Boeing, H.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Genetics of Stroke
Right arrow Primary and Secondary Stroke Prevention
Right arrow Epidemiology

Submitted on February 22, 2007
Revised on April 20, 2007
Accepted on April 23, 2007

B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort

Cornelia Weikert MD, MPH*; Jutta Dierkes PhD; Kurt Hoffmann PhD; Klaus Berger MD, MPH; Dagmar Drogan MPH; Kerstin Klipstein-Grobusch MSc, PhD; Joachim Spranger MD; Matthias Möhlig MD; Claus Luley MD; and Heiner Boeing MSPH, PhD

From the Department of Epidemiology (C.W., K.H., D.D., K.-K.G., H.B.), German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany; the Institute of Clinical Chemistry and Pathobiochemistry (J.D., C.L.), Otto-von-Guericke University, Magdeburg, Germany; the Institute of Epidemiology and Social Medicine (K.B.), University of Muenster, Muenster, Germany; the School of Public Health (K.K.-G.), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; and the Department of Clinical Nutrition (J.S., M.M.), German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany.

* To whom correspondence should be addressed. E-mail: Weikert{at}mail.dife.de.

Background and Purpose—Data from prospective studies on the associations between B vitamin plasma levels and the risk of stroke are limited. We investigated the individual and combined effects of plasma folate, vitamin B12, and pyridoxal 5-phophate (PLP) levels on the risk of ischemic stroke and transient ischemic attack (TIA) in a large, prospective German cohort.

Methods—Incident cases of ischemic stroke or TIA were identified among 25 770 participants (age 35 to 65 years) of the European Prospective Investigation into Cancer and Nutrition-Potsdam Study during 6.0±1.5 years of follow-up. The present analysis is based on a case-cohort study comprising 779 subjects free from cardiovascular disease and 188 incident cases of cerebral ischemia (ischemic stroke or TIA). Multivariable Cox proportional-hazard models were applied to evaluate the association between B vitamin levels and risk of cerebral ischemia.

Results—Participants in the lowest tertile of vitamin B12 values were at increased risk of cerebral ischemia compared with subjects in the highest tertile; this was not observed, however, for either folate or PLP. In subgroup analyses, the relative risks were similar in magnitude for stroke and TIA. When various combinations of B vitamin tertile levels were analyzed, only combined low folate and vitamin B12 levels (relative risk, 2.24; 95% CI, 1.10 to 4.54) were significantly related to an increased risk of cerebrovascular ischemia.

Conclusions—Our data suggest that low vitamin B12 plasma levels, particularly in combination with low folate levels, increase the risk of cerebral ischemia. This effect may be mediated at least partly through elevations of homocysteine levels.


Key words: cerebrovascular ischemia • folate • methylene tetrahydrofolate reductase 677 genotype • pyridoxal 5-phosphate • vitamin B12




This article has been cited by other articles:


Home page
StrokeHome page
B. Pieters, J. Staals, I. Knottnerus, R. Rouhl, P. Menheere, A. Kessels, and J. Lodder
Periventricular White Matter Lucencies Relate to Low Vitamin B12 Levels in Patients With Small Vessel Stroke
Stroke, May 1, 2009; 40(5): 1623 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Vogiatzoglou, A D. Smith, E. Nurk, P. Berstad, C. A Drevon, P. M Ueland, S. E Vollset, G. S Tell, and H. Refsum
Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homocysteine Study
Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1078 - 1087.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L.-C. Weng, W.-T. Yeh, C.-H. Bai, H.-J. Chen, S.-Y. Chuang, H.-Y. Chang, B.-F. Lin, K.-J. Chen, and W.-H. Pan
Is Ischemic Stroke Risk Related to Folate Status or Other Nutrients Correlated With Folate Intake?
Stroke, December 1, 2008; 39(12): 3152 - 3158.
[Abstract] [Full Text] [PDF]